Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.50 Price Target
Healthcare & PharmaceuticalCompany Update

Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.50 Price Target

January 22, 2026 6:00 AM

Emerging Growth Research today released a Flash Research Update on Immuron Limited (Nasdaq:IMRN), maintaining its Buy-Extended rating and 12-month price target of $3.50 following the Company's release of first-half fiscal year 2026 operating results.The Flash Report notes that Immuron reported global revenue of AUD$4.2 million for the six months ended December 31, 2025, representing a 5% increase compared to the prior-year period. Sales growth...

Read more
Preventative Oral Healthcare Tips for 2026 Shared by Dentist Dr. Andrea Joy Smith, DICOI
Healthcare & PharmaceuticalCompany Update

Preventative Oral Healthcare Tips for 2026 Shared by Dentist Dr. Andrea Joy Smith, DICOI

January 22, 2026 12:40 AM

Dr. Andrea Joy Smith has shared updated guidance on preventative dental care to help patients reduce the risk of common oral health problems in 2026 in a new blog post.Nearly half of adults over the age of 30 experience some form of gum disease, and many also develop other preventable oral health issues such as tooth decay, enamel wear, or jaw-related symptoms over time. Preventative dental care focuses on identifying and addressing concerns...

Read more
Onco-Innovations Engages i2i Marketing Group Engagement for Market Awareness Services
Healthcare & PharmaceuticalCompany Update

Onco-Innovations Engages i2i Marketing Group Engagement for Market Awareness Services

January 21, 2026 6:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") announces that it has engaged i2i Marketing Group, LLC (1107 Key Plaza, Suite 222, Key West, FL 33040, USA; email: [email protected]; telephone: (240) 315-4665; Contact: Joe Grubb) to provide market awareness and corporate communications services, including through content creation, project management, third-party media distribution, and...

Read more
Neuro Serge Reviews (2026 URGENT REPORT) Cognitive Support Benefits, Risks & Who Should Avoid It
Healthcare & PharmaceuticalAdvertorial

Neuro Serge Reviews (2026 URGENT REPORT) Cognitive Support Benefits, Risks & Who Should Avoid It

January 21, 2026 5:45 PM

Cognitive decline, brain fog, and focus loss are no longer slow-burning problems, they're immediate performance blockers, and millions are feeling them daily. That urgency is exactly why Neuro Serge Reviews exploded going into 2026. Unlike outdated nootropics that require weeks of buildup, Neuro Serge is widely reported to deliver noticeable cognitive clarity, sharper focus, and mental energy within days, without stimulants, crashes, or side...

Read more
From Policy to Practice: Wendy Gregg's Impact on Assisted Living and Medicaid Integration
Healthcare & PharmaceuticalCompany Update

From Policy to Practice: Wendy Gregg's Impact on Assisted Living and Medicaid Integration

January 21, 2026 2:59 PM

Healthcare executive and consultant Wendy Gregg, MSW, MBA, continues to translate healthcare policy into practical solutions that expand access to assisted living through effective Medicaid integration. With more than 25 years of experience across healthcare administration, senior living operations, and social services, Gregg has built a career focused on aligning regulation, funding, and care delivery to better serve underserved populations.Her...

Read more
Electiva Announces Flagship London Hospital
Healthcare & PharmaceuticalCompany Update

Electiva Announces Flagship London Hospital

January 21, 2026 1:55 PM

Electiva Healthcare is proud to announce that it will open a new hospital in London in Summer 2026. The Electiva London Hospital will set a new standard in luxury and exclusivity in a new purpose-built development in South-West London on the banks of the River Thames.The elite hospital will become Electiva's flagship site combining patient first healthcare with a luxurious experience. It will house two fully equipped state of the art surgical...

Read more
MemoryFuel Reviews (2026 URGENT REPORT) Does This Non-Stimulant Brain Supplement Actually Improve Memory & Focus?
Healthcare & PharmaceuticalAdvertorial

MemoryFuel Reviews (2026 URGENT REPORT) Does This Non-Stimulant Brain Supplement Actually Improve Memory & Focus?

January 21, 2026 1:15 PM

In 2026, cognitive performance has quietly become one of the most valuable personal assets. Professionals, students, and aging adults alike are no longer just looking for "energy", they are searching for clarity, recall, and mental endurance without stimulation, crashes, or dependency. This shift has sparked renewed interest in non-stimulant brain support supplements that work with the brain's biology rather than forcing short-term performance...

Read more
Black Book Research Publishes 2026-2027 Update:
Healthcare & PharmaceuticalProduct Announcements

Black Book Research Publishes 2026-2027 Update: "Global Growth Opportunities for openEHR Adoption"

January 21, 2026 11:45 AM

Black Book Research today announced the availability of its updated market intelligence report, "Global Growth Opportunities for openEHR Adoption in 2026-2027." Industry stakeholders can download a complimentary copy at https://blackbookmarketresearch.com/global-growth-opportunities-for-openehr-adoption-in-2026-2027The 2026-2027 update refreshes Black Book's baseline readiness analysis and details why openEHR's global momentum is increasingly...

Read more
TridentCare Announces Acquisition of DispatchHealth's Imaging Business Unit
Healthcare & PharmaceuticalMergers and Acquisitions

TridentCare Announces Acquisition of DispatchHealth's Imaging Business Unit

January 21, 2026 11:30 AM

TridentCare, the nation's leading provider of portable diagnostic services, announced its acquisition of DispatchHealth's imaging business unit, effective January 20, 2026. This strategic transaction underscores TridentCare's commitment to advancing in-home care, broadening market presence, and delivering exceptional service to patients and providers nationwide.The Imaging division of DispatchHealth operates across 16 states, offering portable...

Read more
Dr. Nikesh Seth Calls for a More Human Approach to Pain Care
Healthcare & PharmaceuticalCompany Update

Dr. Nikesh Seth Calls for a More Human Approach to Pain Care

January 21, 2026 11:05 AM

Dr. Nikesh Seth, a board-certified anesthesiologist and interventional pain management physician, is calling on patients and healthcare providers alike to rethink how chronic pain is treated-placing empathy, innovation, and informed choice at the center of care.With more than 15 years of clinical experience, Dr. Seth is raising awareness about the need for individualized, minimally invasive approaches that go beyond symptom management to focus...

Read more
Medical Care Technologies Inc. (OTC Pink:MDCE) Completes Marketing Content for First AI-Based Lifestyle App Ahead of Imminent Launch
Healthcare & PharmaceuticalCompany Update

Medical Care Technologies Inc. (OTC Pink:MDCE) Completes Marketing Content for First AI-Based Lifestyle App Ahead of Imminent Launch

January 21, 2026 9:30 AM

Medical Care Technologies Inc. (OTC Pink:MDCE) ("Medical Care Technologies" or the "Company"), a developer of AI-driven lifestyle, wellness, and medical pre-screening mobile applications, today provided a corporate update highlighting a major milestone in preparation for its first consumer app launch.The Company has successfully completed the creation of its full social media and digital marketing campaign content for its first AI-based...

Read more
Curiteva Surpasses More Than 10,000 Levels Successfully Treated
Healthcare & PharmaceuticalCompany Update

Curiteva Surpasses More Than 10,000 Levels Successfully Treated

January 21, 2026 9:30 AM

Curiteva, Inc., a privately held, technology and manufacturing company, is proud to announce the significant achievement of over 10,000 levels successfully treated using the Inspire implant portfolio. With 5,000 interbodies implanted in just the last several months, this milestone underscores the rapid market adoption and transformative impact of the company's novel 3D-printed Trabecular PEEK with HAFUSEtechnology. This achievement coincides...

Read more
EDGE Surgical Signs Agreement with 3Di Medical to Accelerate Adoption of Ortho EDG(R) Across Florida Hospitals
Healthcare & PharmaceuticalPartnerships

EDGE Surgical Signs Agreement with 3Di Medical to Accelerate Adoption of Ortho EDG(R) Across Florida Hospitals

January 21, 2026 9:00 AM

EDGE Surgical, Inc., the innovative brand behind the world's only electronic depth gauge for orthopedic surgery, today announced a $225,000 agreement appointing 3Di Medical as an authorized distributor for the Ortho EDG® Universal Electronic Depth Gauge in Florida.This relationship comes at a critical juncture, propelled by the rapidly growing demand for the Ortho EDG®. Integral to the EDGE Surgical commercialization efforts, 3Di Medical will...

Read more
Alpha Genesis Announces Research Animal Retirement and Lifetime Care Program to Preserve Animal Welfare, Research Continuity, and National Preparedness
Healthcare & PharmaceuticalCompany Update

Alpha Genesis Announces Research Animal Retirement and Lifetime Care Program to Preserve Animal Welfare, Research Continuity, and National Preparedness

January 21, 2026 9:00 AM

Alpha Genesis Inc., the largest nonhuman primate breeding and research services organization in the United States, today announced the expansion of its long-term research animal retirement and lifetime care services. The program is designed to provide dignified, humane, and fiscally responsible lifelong care for nonhuman primates that have completed participation in biomedical research.The announcement comes as multiple National Primate Research...

Read more
New Year, New Feet: Simple Steps to Healthier Feet in 2026
Healthcare & PharmaceuticalCompany Update

New Year, New Feet: Simple Steps to Healthier Feet in 2026

January 21, 2026 9:00 AM

As people across the country set health goals for the new year, foot health is often overlooked-yet it plays a critical role in overall wellness, mobility, and quality of life. To help patients start 2026 on the right foot, Ankle & Foot Centers of America is sharing simple, practical habits anyone can begin this January to support healthier feet all year long."Your feet are the foundation of your body," explains a podiatry specialist with Ankle...

Read more
Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI
Healthcare & PharmaceuticalCompany Update

Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI

January 21, 2026 8:30 AM

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation, announced that the Company has reached agreement with the FDA on an approval pathway for Gemini as a treatment for Acute Kidney Injury (AKI). The two key agreements were 1) a clinically relevant and objective composite endpoint comprising death and/or need for dialysis, and 2) positive...

Read more
Ensysce Biosciences Expands Global Opioid Patent Portfolio
Healthcare & PharmaceuticalProduct Announcements

Ensysce Biosciences Expands Global Opioid Patent Portfolio

January 21, 2026 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for novel therapeutics while reducing the potential for abuse and overdose, today announced it received a Notice of Allowance from the Brazilian Patent Office for the issuance of a patent* covering additional opioid families, utilizing the Company's proprietary TAAP™ (Trypsin Activated Abuse Protection)...

Read more
Aspire Biopharma's Unveils Bold New Era for BUZZ BOMB(TM) Caffeine with Dynamic Website and Packaging Redesign
Healthcare & PharmaceuticalProduct Announcements

Aspire Biopharma's Unveils Bold New Era for BUZZ BOMB(TM) Caffeine with Dynamic Website and Packaging Redesign

January 21, 2026 8:00 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending delivery technology, is proud to announce the launch of a comprehensive brand redesign for its flagship caffeine product, BUZZ BOMB™. This strategic rebranding initiative introduces a new logo, sleek, modern website and eye-catching product packaging, reflecting the product's capabilities and Aspire...

Read more
The Holy Grail of Cardiology Has Arrived
Healthcare & PharmaceuticalProduct Announcements

The Holy Grail of Cardiology Has Arrived

January 21, 2026 7:40 AM

Today marks one of the most profound moments in the history of cardiovascular medicine.A newly published, peer-reviewed multi-center retrospective case series has delivered irrefutable evidence that high-viscosity 2-Hydroxypropyl-β-cyclodextrin (Cavadex) can reverse established coronary artery calcification, a biological outcome long considered impossible.Published Paper:Longitudinal Retrospective Analysis of High-Viscosity...

Read more
enBio Appoints Robert Lewis to Advisory Board Effective January 21
Healthcare & PharmaceuticalCompany Update

enBio Appoints Robert Lewis to Advisory Board Effective January 21

January 21, 2026 7:00 AM

enBio Corp., a rapidly growing provider of biomedical, hospital bed management, and HTM services, today announced the appointment of Robert Lewis to its Advisory Board, effective January 21. Robert Lewis brings more than three decades of senior leadership experience in healthcare sales, market development, and capital equipment strategy. Most recently, he served as Regional Sales Leader for Life Care Solutions at GE Healthcare, where he led...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?